Log In Sign up
The largest database of trusted experimental protocols

Cellcheck 19 plus

Manufactured by IDEXX
Visit Supplier

The CellCheck 19 plus is a laboratory equipment product designed for automated analysis of cell samples. It provides quantitative and qualitative data on various cell types and parameters. The core function of the CellCheck 19 plus is to perform comprehensive cell analysis, delivering objective and reliable results.

Automatically generated - may contain errors

Lab products found in correlation

C57bl 6 and c3h hej mice, by Jackson ImmunoResearch (2 mentions)

Close spelling variants of this product

CellCheck

2 protocols using cellcheck 19 plus

1

Syngeneic Tumor Propagation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight to 10-week-old female C57BL/6 and C3H/HeJ mice (The Jackson
Laboratory) were maintained in AALAC-accredited facilities and all procedures
approved by the Institutional Animal Care and Use Committee (IACUC) at the
University of Pennsylvania (Philadelphia, PA). To propagate fibrosarcoma
syngeneic tumors, 5×105 cells from a sarcoma line established
from the
LSL-KrasG12D/wt;p53FL/FLGEMM model (C57BL/6 background) at the 5th passage or
3×105 cells of the established RIF mouse sarcoma cell line
(C3H/HeJ background, RRID:IMSR_JAX:000659) at the 9th passage were
injected subcutaneously or intramuscularly in the right thigh. Cells from the
LSL-KrasG12D/wt;p53FL/FLGEMM model were recently isolated for the purpose of this research. The
established RIF cell line has been maintained in the laboratory of Dr. Busch for
more than 20 years and originated from cells of the same line at Roswell Park
Cancer Institute in Buffalo, NY. Both cell lines were authenticated and tested
mycoplasma negative by IDEXX BioAnalytics (CellCheck 19 plus) in 2021. Tumors
were irradiated upon reaching 100 mm3 in volume. Tumor size was
measured utilizing calipers and volume was calculated as: (Length ×
Width2)/2.
Velalopoulou A., Karagounis I.V., Cramer G.M., Kim M.M., Skoufos G., Goia D., Hagan S., Verginadis I.I., Shoniyozov K., Chiango J., Cerullo M., Varner K., Yao L., Qin L., Hatzigeorgiou A.G., Minn A.J., Putt M., Lanza M., Assenmacher C.A., Radaelli E., Huck J., Diffenderfer E., Dong L., Metz J., Koumenis C., Cengel K.A., Maity A, & Busch T.M. (2021). FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response. Cancer Research, 81(18), 4808-4821.
+ Open protocol
+ Expand
2

Syngeneic Fibrosarcoma Tumor Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight- to 10-week-old female C57BL/6 and C3H/HeJ mice (The Jackson Laboratory) were maintained in Association for Assessment and Accreditation of Laboratory Animal Care–accredited facilities and all procedures approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Pennsylvania. To propagate fibrosarcoma syngeneic tumors, 5 × 105 cells from a sarcoma line established from the LSL-KrasG12D/wt;p53FL/FL genetically engineered mouse model (GEMM) model (C57BL/6 background) at the fifth passage or 3 × 105 cells of the established RIF mouse sarcoma cell line (C3H/HeJ background, RRID:IMSR_JAX:000659) at the nineth passage were injected subcutaneously or intramuscularly in the right thigh. Cells from the LSL-KrasG12D/wt;p53FL/FL GEMM model were recently isolated for the purpose of this research. The established RIF cell line has been maintained in the laboratory of Dr. Busch for more than 20 years and originated from cells of the same line at Roswell Park Cancer Institute in Buffalo, NY. Both cell lines were authenticated and tested Mycoplasma negative by IDEXX BioAnalytics (CellCheck 19 plus) in 2021. Tumors were irradiated upon reaching 100 mm3 in volume. Tumor size was measured utilizing calipers and volume was calculated as (length × width2)/2.
Velalopoulou A., Karagounis I.V., Cramer G.M., Kim M.M., Skoufos G., Goia D., Hagan S., Verginadis I.I., Shoniyozov K., Chiango J., Cerullo M., Varner K., Yao L., Qin L., Hatzigeorgiou A.G., Minn A.J., Putt M., Lanza M., Assenmacher C.A., Radaelli E., Huck J., Diffenderfer E., Dong L., Metz J., Koumenis C., Cengel K.A., Maity A, & Busch T.M. (2021). FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response. Cancer Research, 81(18), 4808-4821.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!